Literature DB >> 17224754

The results of screening frequency doubling technology perimetry in different locations of the community.

Steven L Mansberger1, Chris A Johnson, George A Cioffi.   

Abstract

PURPOSE: To determine the effect of screening location on the frequency of abnormal test results with Frequency Doubling Technology (FDT) perimetry.
DESIGN: Retrospective cross-sectional study.
METHODS: The Vision Screening Outreach Project conducted FDT testing in community sites surrounding Portland, Oregon. The sites were separated into a specific location type: health care clinics, work sites, senior centers, festivals/fairs, food banks/shelters, and other locations. These locations were compared for differences in the proportion of screening failures. MAIN OUTCOME MEASURES: Screening failure (defined as a repeatable, abnormal FDT result in either eye).
RESULTS: There were 9052 participants from 211 locations in Oregon and Washington. On initial FDT testing, the right and left eye had abnormal results in 18% (1654/9052) and 21% (1918/9052) of participants. Of those with abnormal FDT results, approximately 30% of eyes reverted to normal on repeat testing. Overall, 13% of participants were screening failures. Screening failure was highly associated with age (P<0.001). After controlling for age, participants at senior centers (P<0.001) were most likely to be screening failures and participants at work sites (P=0.006) were least likely to be screening failures when compared with health clinics.
CONCLUSIONS: An investigator should repeat an initially abnormal FDT result when screening with FDT. Age and the location of testing influence the probability of a screening failure. Screening in senior centers is most likely to result in screening failure. However, only a randomized controlled trial can determine the true benefit of FDT screening in these locations.

Entities:  

Mesh:

Year:  2007        PMID: 17224754     DOI: 10.1097/01.ijg.0000243481.75155.97

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  Predictive value of screening tests for visually significant eye disease.

Authors:  Laura J Kopplin; Steven L Mansberger
Journal:  Am J Ophthalmol       Date:  2015-06-04       Impact factor: 5.258

2.  Five year incidence of visual field loss in adult Chinese. The Beijing Eye Study.

Authors:  Ya Xing Wang; Liang Xu; Xiu Ying Sun; Yang Zou; Hai Tao Zhang; Jost B Jonas
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

3.  Developing the specifications of an open angle glaucoma screening intervention in the United Kingdom: a Delphi approach.

Authors:  Susan E Campbell; Augusto Azuara-Blanco; Marion K Campbell; Jillian J Francis; Alexandra C Greene; Craig R Ramsay; Jennifer M Burr
Journal:  BMC Health Serv Res       Date:  2012-12-05       Impact factor: 2.655

4.  Alzheimer's disease: screening biomarkers using frequency doubling technology visual field.

Authors:  Denise A Valenti
Journal:  ISRN Neurol       Date:  2013-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.